JP2019516104A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019516104A5 JP2019516104A5 JP2018557905A JP2018557905A JP2019516104A5 JP 2019516104 A5 JP2019516104 A5 JP 2019516104A5 JP 2018557905 A JP2018557905 A JP 2018557905A JP 2018557905 A JP2018557905 A JP 2018557905A JP 2019516104 A5 JP2019516104 A5 JP 2019516104A5
- Authority
- JP
- Japan
- Prior art keywords
- ldha
- expression level
- protein
- mmp9
- cadh1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101001090713 Homo sapiens L-lactate dehydrogenase A chain Proteins 0.000 claims 8
- 102100034671 L-lactate dehydrogenase A chain Human genes 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 102000004169 proteins and genes Human genes 0.000 claims 8
- 108090000623 proteins and genes Proteins 0.000 claims 8
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 claims 5
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 5
- 102100034613 Annexin A2 Human genes 0.000 claims 4
- -1 CADH1 Proteins 0.000 claims 4
- 102000003952 Caspase 3 Human genes 0.000 claims 4
- 108090000397 Caspase 3 Proteins 0.000 claims 4
- 102100034667 Chloride intracellular channel protein 1 Human genes 0.000 claims 4
- 206010014733 Endometrial cancer Diseases 0.000 claims 4
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 4
- 102100030421 Fatty acid-binding protein 5 Human genes 0.000 claims 4
- 102100030943 Glutathione S-transferase P Human genes 0.000 claims 4
- 101150096895 HSPB1 gene Proteins 0.000 claims 4
- 102100039165 Heat shock protein beta-1 Human genes 0.000 claims 4
- 101000924474 Homo sapiens Annexin A2 Proteins 0.000 claims 4
- 101000946430 Homo sapiens Chloride intracellular channel protein 1 Proteins 0.000 claims 4
- 101001062855 Homo sapiens Fatty acid-binding protein 5 Proteins 0.000 claims 4
- 101001010139 Homo sapiens Glutathione S-transferase P Proteins 0.000 claims 4
- 101000760817 Homo sapiens Macrophage-capping protein Proteins 0.000 claims 4
- 101001124867 Homo sapiens Peroxiredoxin-1 Proteins 0.000 claims 4
- 101001072202 Homo sapiens Protein disulfide-isomerase Proteins 0.000 claims 4
- 102000034655 MIF Human genes 0.000 claims 4
- 108060004872 MIF Proteins 0.000 claims 4
- 102100024573 Macrophage-capping protein Human genes 0.000 claims 4
- 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 claims 4
- 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 claims 4
- 102100029139 Peroxiredoxin-1 Human genes 0.000 claims 4
- 102100036352 Protein disulfide-isomerase Human genes 0.000 claims 4
- 102100021916 Sperm-associated antigen 1 Human genes 0.000 claims 4
- 101710098550 Sperm-associated antigen 1 Proteins 0.000 claims 4
- 208000019585 progressive encephalomyelitis with rigidity and myoclonus Diseases 0.000 claims 4
- 239000012530 fluid Substances 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 210000000056 organ Anatomy 0.000 claims 3
- 230000001850 reproductive effect Effects 0.000 claims 3
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023003700A JP7492287B2 (ja) | 2016-05-04 | 2023-01-13 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
| JP2024077227A JP2024116127A (ja) | 2016-05-04 | 2024-05-10 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16168328.9 | 2016-05-04 | ||
| EP16168328 | 2016-05-04 | ||
| PCT/EP2017/057635 WO2017190896A1 (en) | 2016-05-04 | 2017-03-30 | Mmp9 as marker of endometrial cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023003700A Division JP7492287B2 (ja) | 2016-05-04 | 2023-01-13 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019516104A JP2019516104A (ja) | 2019-06-13 |
| JP2019516104A5 true JP2019516104A5 (OSRAM) | 2020-04-23 |
| JP7240712B2 JP7240712B2 (ja) | 2023-03-16 |
Family
ID=56096908
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557905A Active JP7240712B2 (ja) | 2016-05-04 | 2017-03-30 | 子宮内膜がんのマーカーとしてのｐｅｒｍ |
| JP2023003700A Active JP7492287B2 (ja) | 2016-05-04 | 2023-01-13 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
| JP2024077227A Pending JP2024116127A (ja) | 2016-05-04 | 2024-05-10 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023003700A Active JP7492287B2 (ja) | 2016-05-04 | 2023-01-13 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
| JP2024077227A Pending JP2024116127A (ja) | 2016-05-04 | 2024-05-10 | 子宮内膜がんのマーカーとしてのｍｍｐ９ |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20190137499A1 (OSRAM) |
| EP (3) | EP4180814A3 (OSRAM) |
| JP (3) | JP7240712B2 (OSRAM) |
| AU (3) | AU2017260806B9 (OSRAM) |
| BR (1) | BR112018072498A2 (OSRAM) |
| CA (2) | CA3286798A1 (OSRAM) |
| DK (1) | DK3452829T3 (OSRAM) |
| ES (1) | ES2974307T3 (OSRAM) |
| FI (1) | FI3452829T3 (OSRAM) |
| PL (1) | PL3452829T3 (OSRAM) |
| PT (1) | PT3452829T (OSRAM) |
| WO (1) | WO2017190896A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3655778T3 (da) * | 2017-07-21 | 2023-07-31 | Fundacio Hospital Univ Vall D Hebron Institut De Recerca | Agrin som en markør for endometriecancer |
| CN118556133A (zh) | 2021-07-23 | 2024-08-27 | 瓦尔德西布伦大学医院基金会研究所 | 子宫内膜癌的生物标记物 |
| CN113493838B (zh) * | 2021-09-06 | 2021-11-23 | 北京泱深生物信息技术有限公司 | 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用 |
| KR102640230B1 (ko) * | 2021-09-24 | 2024-02-22 | 가천대학교 산학협력단 | C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| AUPO573697A0 (en) * | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
| EP2251695B1 (en) * | 2003-12-23 | 2013-07-17 | Mount Sinai Hospital Corporation | Markers associated with endometrial disease |
| WO2008003024A2 (en) * | 2006-06-28 | 2008-01-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Method and composition for diagnosing endometrial cancer |
| US8329399B2 (en) * | 2006-10-27 | 2012-12-11 | Siu K W Michael | Endometrial biomarkers |
| DK2456889T3 (en) * | 2009-07-24 | 2014-12-01 | Geadic Biotec Aie | Markers of endometrial cancer |
-
2017
- 2017-03-30 CA CA3286798A patent/CA3286798A1/en active Pending
- 2017-03-30 US US16/098,813 patent/US20190137499A1/en not_active Abandoned
- 2017-03-30 DK DK17713973.0T patent/DK3452829T3/da active
- 2017-03-30 EP EP23150361.6A patent/EP4180814A3/en active Pending
- 2017-03-30 EP EP25190526.1A patent/EP4610655A3/en active Pending
- 2017-03-30 BR BR112018072498A patent/BR112018072498A2/pt active IP Right Grant
- 2017-03-30 WO PCT/EP2017/057635 patent/WO2017190896A1/en not_active Ceased
- 2017-03-30 PT PT177139730T patent/PT3452829T/pt unknown
- 2017-03-30 FI FIEP17713973.0T patent/FI3452829T3/fi active
- 2017-03-30 JP JP2018557905A patent/JP7240712B2/ja active Active
- 2017-03-30 AU AU2017260806A patent/AU2017260806B9/en active Active
- 2017-03-30 EP EP17713973.0A patent/EP3452829B1/en active Active
- 2017-03-30 CA CA3022586A patent/CA3022586A1/en active Pending
- 2017-03-30 PL PL17713973.0T patent/PL3452829T3/pl unknown
- 2017-03-30 ES ES17713973T patent/ES2974307T3/es active Active
-
2022
- 2022-11-09 US US17/984,197 patent/US20230221323A1/en not_active Abandoned
-
2023
- 2023-01-13 JP JP2023003700A patent/JP7492287B2/ja active Active
- 2023-08-02 AU AU2023210591A patent/AU2023210591B9/en active Active
-
2024
- 2024-05-10 JP JP2024077227A patent/JP2024116127A/ja active Pending
-
2025
- 2025-09-01 AU AU2025223935A patent/AU2025223935A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Steiner et al. | Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University | |
| Yuan et al. | Tenascin-X is a novel diagnostic marker of malignant mesothelioma | |
| JP2019516104A5 (OSRAM) | ||
| WO2014140933A3 (en) | Method for the prognosis and treatment of cancer metastasis | |
| JP2018148931A5 (OSRAM) | ||
| JP2016536568A5 (OSRAM) | ||
| HRP20190533T1 (hr) | Postupak za otkrivanje nukleosoma koji sadrže nukleotide | |
| JP2019500582A5 (OSRAM) | ||
| Kuhs et al. | Characterization of human papillomavirus antibodies in individuals with head and neck cancer | |
| MX2018012580A (es) | Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia. | |
| Larque et al. | p16INK4a overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas | |
| Shiozaki et al. | Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?: the remaining controversy and review of the literature | |
| JP2018536849A5 (OSRAM) | ||
| KR102047502B1 (ko) | 포타슘 채널 단백질을 이용한 암 진단용 조성물 | |
| Leung et al. | Ovarian cancer biomarkers: current state and future implications from high-throughput technologies | |
| FI3655778T3 (fi) | Agriini endometriumsyövän markkerina | |
| DK2054443T3 (da) | Antistoffer mod en epitop fra AGR2, assays og hybridomer | |
| Hanna et al. | Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma | |
| JP2018515071A5 (OSRAM) | ||
| Takeda et al. | The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma | |
| Viswanathan et al. | Orthopedia homeobox protein (OTP) is a sensitive and specific marker for primary pulmonary carcinoid tumors in cytologic and surgical specimens | |
| EP4180814A3 (en) | Markers of endometrial cancer | |
| JP2020512549A5 (OSRAM) | ||
| Nam et al. | A new cell block method for multiple immunohistochemical analysis of circulating tumor cells in patients with liver cancer | |
| JP2016519767A5 (OSRAM) |